Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -83.89% | 49.56% | |||
| Total Other Revenue | 82.46% | 42.18% | |||
| Total Revenue | -83.50% | 49.54% | |||
| Cost of Revenue | -42.39% | 23.41% | |||
| Gross Profit | -93.67% | 57.81% | |||
| SG&A Expenses | -38.78% | 26.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.11% | 20.59% | |||
| Operating Income | -192.36% | 217.66% | |||
| Income Before Tax | -207.96% | 199.75% | |||
| Income Tax Expenses | -177.64% | 4,946.93% | |||
| Earnings from Continuing Operations | -221.64% | 102.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -221.64% | 102.62% | |||
| EBIT | -192.36% | 217.66% | |||
| EBITDA | -173.27% | 178.42% | |||
| EPS Basic | -258.80% | 141.66% | |||
| Normalized Basic EPS | -190.96% | 212.13% | |||
| EPS Diluted | -267.20% | 138.91% | |||
| Normalized Diluted EPS | -194.75% | 209.08% | |||
| Average Basic Shares Outstanding | 0.70% | 0.02% | |||
| Average Diluted Shares Outstanding | -3.34% | 1.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||